top of page

CogMe

AI-powered Delirium Prediction, Detection, and Prevention

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
CogMe
02/07/2022
NeuroreHabilitation | NeuroDegenerative | NeuralProstheses
Digital & Health care
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
01/01/2020
"1-10"
CogMe
Go to company site

CogMe aims to reduce cognitive drops in at-risk populations, initially focusing on delirium in an inpatient setting. Using artificial intelligence, CogMe’s comprehensive solution will analyze the cognitive and biological indicators of individual patients to predict, detect, and intervene in order to prevent cognitive drops.

bottom of page